W E Evans|M V Relling - JoVE Visualize

Showing results (11-20 of 342) with videos related to

Pageof 35

Sort By:

British Journal of Clinical Pharmacology|September 1, 1991

Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.

Blood|April 1, 1995

Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemiaH L McLeod, M V Relling, Q Liu, et al.

Journal of Paediatrics and Child Health|February 1, 1997

Cytochrome P450 2D6 and glutathione S-transferase genotype in sudden infant death syndromeC L Chen, Q Liu, W E Evans, et al.

Clinical Pharmacology and Therapeutics|September 6, 2012

Pharmacogenomics and individualized medicine: translating science into practiceK R Crews, J K Hicks, C-H Pui, et al.

Clinical Pharmacology and Therapeutics|August 1, 1991

Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrineW R Crom, M V Relling, M L Christensen, et al.

Blood|April 27, 1999

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemiaM V Relling, M L Hancock, J M Boyett, et al.

Clinical Pharmacology and Therapeutics|June 1, 1987

Simultaneous administration of multiple model substrates to assess hepatic drug clearanceW R Crom, S L Webster, L Bobo, et al.

Clinical Pharmacology and Therapeutics|May 1, 1989

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.

The Journal of Clinical Investigation|May 1, 1993

Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black AmericansW E Evans, M V Relling, A Rahman, et al.

Clinical Pharmacology and Therapeutics|August 8, 1998

Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humansT Loennechen, C R Yates, M Y Fessing, et al.

Pageof 35

Showing results (11-20 of 342) with videos related to

Sort By:

Pageof 35

British Journal of Clinical Pharmacology|September 1, 1991

Phenotypic debrisoquine 4-hydroxylase activity among extensive metabolizers is unrelated to genotype as determined by the Xba-I restriction fragment length polymorphismJ Turgeon, W E Evans, M V Relling, et al.

Blood|April 1, 1995

Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemiaH L McLeod, M V Relling, Q Liu, et al.

Journal of Paediatrics and Child Health|February 1, 1997

Cytochrome P450 2D6 and glutathione S-transferase genotype in sudden infant death syndromeC L Chen, Q Liu, W E Evans, et al.

Clinical Pharmacology and Therapeutics|September 6, 2012

Pharmacogenomics and individualized medicine: translating science into practiceK R Crews, J K Hicks, C-H Pui, et al.

Clinical Pharmacology and Therapeutics|August 1, 1991

Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrineW R Crom, M V Relling, M L Christensen, et al.

Blood|April 27, 1999

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemiaM V Relling, M L Hancock, J M Boyett, et al.

Clinical Pharmacology and Therapeutics|June 1, 1987

Simultaneous administration of multiple model substrates to assess hepatic drug clearanceW R Crom, S L Webster, L Bobo, et al.

Clinical Pharmacology and Therapeutics|May 1, 1989

Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in childrenW E Evans, M V Relling, W P Petros, et al.

The Journal of Clinical Investigation|May 1, 1993

Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black AmericansW E Evans, M V Relling, A Rahman, et al.

Clinical Pharmacology and Therapeutics|August 8, 1998

Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humansT Loennechen, C R Yates, M Y Fessing, et al.

Pageof 35